MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi) Treatment-Naïve Patients With Myelofibrosis: Updated Results and Subgroup Analyses from XPORT-MF-034
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
myelofibrosis,selinexor,ruxolitinib,phase I
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要